← Back to Screener
Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)
Price$13.09
Favorite Metrics
Price vs S&P 500 (26W)-8.95%
Price vs S&P 500 (4W)-13.71%
Market Capitalization$11.06B
P/E Ratio (Annual)18.22x
Indicated Dividend Yield (Annual)0.65%
All Metrics
P/CF (Annual)22.20x
Book Value / Share (Quarterly)$4.64
P/TBV (Annual)4.00x
Indicated Dividend (Annual)$0.09
Revenue Growth (3Y)14.86%
Cash Flow / Share (Quarterly)$0.24
Payout Ratio (TTM)49.43%
Price vs S&P 500 (YTD)-7.12%
Gross Margin (TTM)65.76%
Net Profit Margin (TTM)16.06%
EPS (TTM)$0.72
10-Day Avg Trading Volume2.25M
EPS Excl Extra (TTM)$0.72
Revenue Growth (5Y)13.26%
EPS (Annual)$0.73
Dividend / Share (Annual)$0.09
ROI (Annual)14.79%
Gross Margin (Annual)66.97%
Net Profit Margin (5Y Avg)15.18%
Cash / Share (Quarterly)$0.95
P/E Basic Excl Extra (TTM)18.51x
Revenue Growth QoQ (YoY)4.44%
EPS Growth (5Y)-11.09%
P/E Normalized (Annual)18.22x
ROA (Last FY)11.44%
Revenue Growth TTM (YoY)11.06%
EBITD / Share (TTM)$1.22
ROE (5Y Avg)15.68%
Operating Margin (TTM)17.74%
Cash Flow / Share (Annual)$0.16
P/B Ratio2.86x
P/B Ratio (Quarterly)2.83x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)6.22x
Net Interest Coverage (TTM)13.50x
ROA (TTM)5.67%
EPS Growth QoQ (YoY)-14.29%
EV / EBITDA (TTM)22.23x
EPS Incl Extra (Annual)$0.73
Current Ratio (Annual)1.92x
Quick Ratio (Quarterly)1.35x
3-Month Avg Trading Volume1.67M
52-Week Price Return29.85%
EV / Free Cash Flow (Annual)89.71x
P/E Incl Extra (TTM)18.51x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.34
P/S Ratio (Annual)3.16x
Asset Turnover (Annual)0.66x
52-Week High$1379.70
Operating Margin (5Y Avg)18.23%
EPS Excl Extra (Annual)$0.73
CapEx CAGR (5Y)41.26%
Tangible BV CAGR (5Y)13.06%
26-Week Price Return-0.20%
Quick Ratio (Annual)1.32x
13-Week Price Return1.32%
Total Debt / Equity (Annual)0.14x
Current Ratio (Quarterly)1.85x
Enterprise Value$11,584.254
Revenue / Share Growth (5Y)-18.00%
Asset Turnover (TTM)0.33x
Book Value / Share Growth (5Y)-15.57%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.54x
Pretax Margin (Annual)23.53%
Cash / Share (Annual)$0.75
3-Month Return Std Dev26.00%
Gross Margin (5Y Avg)65.96%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)25.58%
EBITDA Interim CAGR (5Y)28.74%
ROE (Last FY)16.86%
Net Interest Coverage (Annual)23.53x
EPS Basic Excl Extra (Annual)$0.73
P/FCF (TTM)55.79x
Receivables Turnover (TTM)3.77x
EV / Free Cash Flow (TTM)58.43x
Total Debt / Equity (Quarterly)0.16x
EPS Incl Extra (TTM)$0.72
Receivables Turnover (Annual)3.82x
ROI (TTM)7.34%
Dividend Growth Rate (5Y)-19.44%
P/S Ratio (TTM)2.97x
Pretax Margin (5Y Avg)20.62%
Revenue / Share (Annual)$4.20
Tangible BV / Share (Annual)$3.08
Forward P/E20.62x
Free OCF CAGR (5Y)-12.70%
Price vs S&P 500 (52W)20.79%
P/E Ratio (TTM)18.51x
EPS Growth TTM (YoY)3.72%
Year-to-Date Return-3.17%
5-Day Price Return-0.14%
EPS Normalized (Annual)$0.73
ROA (5Y Avg)10.88%
Net Profit Margin (Annual)17.32%
Month-to-Date Return-1.55%
Cash Flow / Share (TTM)$4.16
EBITD / Share (Annual)$1.14
EPS Growth (3Y)37.21%
Operating Margin (Annual)20.96%
LT Debt / Equity (Annual)0.01x
P/CF (TTM)17.52x
ROI (5Y Avg)14.13%
P/E Excl Extra (TTM)18.51x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$0.72
P/TBV (Quarterly)3.93x
Payout Ratio (Annual)11.78%
P/B Ratio (Annual)2.84x
Dividend / Share (TTM)$0.09
Inventory Turnover (TTM)1.54x
Pretax Margin (TTM)20.75%
Book Value / Share (Annual)$4.33
Price vs S&P 500 (13W)-1.54%
Net Margin Growth (5Y)8.40%
Dividend Yield (TTM)0.65%
Beta0.63x
P/FCF (Annual)85.67x
Revenue / Share (TTM)$4.47
ROE (TTM)8.45%
52-Week Low$1129.00
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
RDYDr. Reddy's Laboratories Limited American Depositary Shares | 2.97x | 11.06% | 65.76% | -11.09% | $13.09 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Dr. Reddy's is one of the world's largest generic pharmaceutical manufacturers with diversified operations spanning generic drugs, injectables, and active pharmaceutical ingredients. The company generates approximately half its generics revenue from North America, with additional significant contributions from India (20%), Russia (10%), and other international markets; injectables represent 25% of North American sales. The company maintains top-five market positions in key Indian therapeutic areas including oncology and gastroenterology through its branded generics portfolio. Its API division manufactures 150+ active ingredients supplied across more than 75 countries.